Jbs N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JBS research report →
Range $17 – $20
Price Chart
About the company
JBS NV is a food company that engages in the sale of beef, pork, lamb meat and poultry products. It offers its products to supermarkets, club stores, other retail distributors, and foodservice companies. The company was founded on October 9, 2019 and is headquartered in Amstelveen, the Netherlands.
- CEO
- Gilberto Tomazoni
- IPO
- 2025
- Employees
- 283,000
- HQ
- Amstelveen, NH, NL
AI snapshot
Six angles, distilled from the data.
The stock is still in a corrective regime after a strong post-IPO run, trading below its 200-day average of 13.96 and well under the 52-week high of 17.27. The setup is stabilizing above the 52-week low of 10.61, with the 50-day average near 12.30 acting as a near-term reference.
Street sentiment is constructive, with a Buy consensus and a 17.23 average target versus a recent close near 12.16. Recent calls have been mixed but still supportive: UBS nudged its target to 17.50 and Stephens trimmed to 17, while the broader rating stack remains tilted bullish.
The earnings profile is uneven, with 2 beats in the last 6 quarters and three straight misses after the March 2026 beat. Next-year EPS is modeled sharply higher at 6.95 from 0.70 TTM, so shareholders should watch whether margin recovery and execution can close the gap to estimates.
Insider activity leans negative on the only discretionary trade: the Global CFO and IRO sold 183,501 shares for about 2.54 million. The rest of the activity is award-related or zero-share entries, which reads more like compensation flow than a conviction signal.
Profitability is modest but positive, with a 3.02% operating margin and 0.76% net margin. Growth is thin at 0.6% revenue growth year over year, while EPS growth remains pressured, but cash generation is substantial with 15.49 billion in operating cash flow and 26.86 billion in free cash flow for 2025.
JBS competes as a global protein processor with scale across beef, pork, poultry, and prepared foods, which supports diversification but keeps margins thin. On valuation, it screens inexpensive at 7.49 times earnings versus the consumer staples group, while the market still discounts its heavy leverage.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $26.79B
- P/E
- 17.70
- Fwd P/E
- 3.18
- PEG
- -2.82
- P/S
- 0.42
- P/B
- 1.76
- EV/EBITDA
- 10.53
- Div Yield
- 8.32%
- Gross Margin
- 11.06%
- Op Margin
- 2.86%
- Net Margin
- 1.10%
- ROE
- 11.74%
- ROIC
- 5.64%
Latest fiscal year · YoY change
- Revenue
- $471.14B+13.0%
- Gross Profit
- $60.33B-3.9%
- Op Income
- $22.63B
- Net Income
- $11.10B+15.4%
- EPS
- $10.41+1201.3%
- OCF Growth
- -34.2%
- FCF Growth
- -73.3%
- 52W High
- $18.65
- 52W Low
- $10.61
- 50D MA
- $12.24
- 200D MA
- $13.88
- Beta
- 0.16
- RSI (14)
- 46
- Avg Volume
- 6.55M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
JBS delivered mixed third-quarter results, with U.S. beef turning positive and Brazil-facing businesses showing signs of recovery into Q4, while pork and poultry remained pressured.· November 10, 2026
- U.S. beef was the standout: management said it returned to positive Adjusted EBITDA under U.S. GAAP after two difficult years.
- Net sales were $23 billion; Adjusted EBITDA was $1.2 billion under IFRS (5.2% margin) and $1 billion under U.S. GAAP (4.4% margin).
- Net income was $164 million and EPS was $0.15; adjusted EPS would have been $0.16.
- Free cash flow was negative $167 million, driven by lower EBITDA and higher working-capital use, especially in Brazil.
- Management sees Q4 improving for Friboi and Seara, while U.S. pork is expected to stay tough into the first half of 2027.
JBS reported third-quarter net sales of $23 billion. Adjusted EBITDA totaled $1.2 billion under IFRS with a 5.2% margin, or $1 billion under U.S. GAAP with a 4.4% margin; excluding biological-asset mark-to-market, IFRS adjusted EBITDA margin would have been 5.5%. Adjusted operating income was $521 million under IFRS and $597 million under U.S. GAAP. Net income was $164 million and EPS was $0.15, while adjusted net income would have been $167 million and EPS $0.16. Free cash flow was negative $167 million, down $551 million year over year. Net leverage ended the quarter at 3.54x, or 3.41x excluding biological-asset mark-to-market. For the outlook, management said Q4 should be stronger than Q3 for U.S. beef and that Seara’s margin should improve versus Q3, helped by a stronger dollar, strong chicken demand, and European inventory releases. They also said Friboi should benefit from resumed China sales tied to the 2027 quota and Brazil seasonality. U.S. pork is expected to remain challenging through at least the first half of 2027. Guilherme Cavalcanti said JBS expects 2026 cash flow breakeven EBITDA of $5.5 billion, based on $2.1 billion of capex, $550 million of working-capital consumption, $100 million of legal settlements, $850 million of biological assets, $1.4 billion of interest expense, $500 million of leasing expense, and a 25% tax rate. He also said capex could fall by around $500 million in 2027.
Gilberto Tomazoni framed the quarter as one of difficult market conditions rather than a break in strategy, citing changing trade flows, poultry margin pressure, and a global pork oversupply. He emphasized that JBS’s diversification across proteins and geographies helps the company navigate cycles, and he repeatedly pointed to brands, efficiency, innovation, and value-added products as core priorities. His tone was constructive, especially around Brazil beef and Seara, where he said the company is already seeing improvement into October and expects a better fourth quarter.
Guilherme Cavalcanti focused on the numbers, the balance sheet, and the implications of the Flora acquisition. He detailed the quarter’s $23 billion of sales, $1.2 billion of IFRS EBITDA, $1 billion of U.S. GAAP EBITDA, $164 million of net income, $0.15 EPS, and negative $167 million of free cash flow, then explained that working-capital consumption was $106 million in the quarter. He also highlighted liquidity of about $8.2 billion including the revolver, average debt term of 14.4 years, average debt cost of 5.7%, and 3.54x net leverage. On capital allocation, he said JBS is prioritizing deleveraging, expects to cut capex by around $500 million in 2027, and sees limited near-term M&A beyond small transactions or share-based deals.
Analysts pressed management on how fast U.S. beef margins can recover, whether the quarter marked a cyclical bottom, and how Mexican cattle imports affect the supply picture. Wesley Batista Filho said Q4 looks stronger than Q3 so far, next year should be much better if cattle supply and demand continue to rebalance, and operational improvements from combining beef units could add around or even above 2 percentage points of margin in 2027. Questions on Flora centered on the tax credits and leverage; Guilherme said JBS has about $800 million in VAT-related credits and $2.2 billion in income tax credits, which Flora can help monetize, and that Flora’s 2027 EBITDA would make its leverage lower than JBS’s. Analysts also asked about U.S. pork’s weak outlook and the gap between U.S. GAAP and IFRS; management said pork should remain tough through the first half of 2027 and that IFRS volatility mainly reflects biological-asset mark-to-market, which does not affect cash.
The strongest bull case from the call is that JBS is seeing real inflection in U.S. beef, with management saying the business returned to positive EBITDA and could improve sequentially in Q4 and again in 2027. Brazil beef and Seara also have visible catalysts in the fourth quarter from seasonal demand, currency, inventory releases, and resumed China-related volumes. On top of that, management presented a path to lower leverage over time through higher EBITDA, lower capex, and possible monetization of tax credits.
The main risks are still centered on weak protein cycles outside U.S. beef, especially U.S. pork, which management expects to stay challenging into the first half of 2027. The quarter also showed negative free cash flow, higher working-capital needs, and leverage at 3.54x, so near-term balance-sheet improvement still depends on execution and market recovery. In addition, Seara and Brazil-facing businesses remain exposed to trade restrictions, export timing, and commodity cost swings, while management said Australia was still being affected by unusual rainfall and U.S. beef recovery is not yet complete.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 33.5%
- Shares Outstanding
- 2.22B
- Float Shares
- 742.56M
of shares held by institutions
291 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bndes Participacoes S.A. | 199.29M | 0 |
| Davis Selected Advisers | 52.23M | ▲ 2.22M |
| Blackrock, Inc. | 31.91M | ▼ 353.26K |
| D. E. Shaw & Co., Inc. | 11.28M | ▲ 4.89M |
| Ubs Group AG | 9.72M | ▲ 6.72M |
| State Street Corp | 8.28M | ▲ 279.07K |
| Brandes Investment Partners, LP | 7.69M | ▲ 4.71M |
| Ameriprise Financial Inc | 6.69M | ▼ 9.89K |
| Alberta Investment Management Corp | 5.90M | 0 |
| Discovery Capital Management, LLC / Ct | 5.44M | ▲ 2.07M |
| Deutsche Bank AG\ | 4.99M | ▲ 106.78K |
| Raymond James Financial Inc | 4.89M | ▲ 329.41K |
Held by 334 ETFs
Biggest fund positions in JBS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 24, 26 | Cavalcanti Guilherme Perboyre | sell | 183,501 |
| Jun 9, 26 | Cavalcanti Guilherme Perboyre | other | 112,098 |
| May 21, 26 | O'Callaghan Jeremiah Alphonsus | other | 49,554 |
| May 21, 26 | O'Callaghan Jeremiah Alphonsus | other | 27,228 |
| May 21, 26 | Cavalcanti Guilherme Perboyre | other | 185,828 |
| Mar 18, 26 | Tomazoni Gilberto | other | 0 |
| Mar 18, 26 | Cavalcanti Guilherme Perboyre | other | 0 |
| Mar 18, 26 | Cavalcanti Guilherme Perboyre | other | 0 |
| Mar 18, 26 | Cavalcanti Guilherme Perboyre | other | 0 |
| Mar 18, 26 | Cavalcanti Guilherme Perboyre | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our JBS coverage
Recent articles, reports, and earnings notes.

JBS N.V. (JBS): Beef Recovery vs. Leverage Risk
JBS offers diversified protein exposure and a visible North American beef recovery, but leverage and earnings volatility keep the stock at Hold. The shares look inexpensive on forward earnings, yet the report still sees enough risk to justify a discount to fair value.

Jbs N.V. (JBS) rises as earnings miss deepens leverage
Jbs N.V. (JBS) rose despite a sharp 3Q26 earnings miss, as investors looked past weaker EPS, EBITDA and free cash flow to segment trends and management’s 2026 cash flow targets. This deep-dive examines margin pressure, leverage, U.S. Beef recovery and what the results mean for the stock.

Jbs N.V. (JBS) slips 1.6% on earnings misses
Jbs N.V. (JBS) slips 1.6% after reporting earnings misses, with investors reacting to weaker-than-expected results and renewed pressure on the stock.
Want a deeper read on JBS?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
JBS N.V. Announces the Expiration and Results of Its Registered Exchange Offers
globenewswire.com · Nov 20
JBS Completes Transaction for Multiprotein Hub in the Middle East
businesswire.com · Nov 19
JBS Q3: Weak Short-Term Results Don't Erase The Long-Term Thesis
seekingalpha.com · Nov 13
JBS N.V. (JBS) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 10
What JBS (JBS) Said on Its Q3 Earnings Call
marketbeat.com · Nov 10
Nvidia, Hims & Hers, JBS, Take-Two, and More Stocks That Explain Today's Market
barrons.com · Nov 10
JBS N.V. (JBS) Q3 Earnings and Revenues Lag Estimates
zacks.com · Nov 9
JBS Reports Lower Profit, Citing Difficult Operating Environment
wsj.com · Nov 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice